A citation-based method for searching scientific literature

Claire C Conley, Monica L Kasting, Bianca M Augusto, Jennifer D Garcia, Deborah Cragun, Brian D Gonzalez, Jongphil Kim, Kimlin Tam Ashing, Cheryl L Knott, Chanita Hughes-Halbert, Tuya Pal, Susan T Vadaparampil. Ann Surg Oncol 2020
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Variant Interpretation: Functional Assays to the Rescue.
Lea M Starita, Nadav Ahituv, Maitreya J Dunham, Jacob O Kitzman, Frederick P Roth, Georg Seelig, Jay Shendure, Douglas M Fowler. Am J Hum Genet 2017
112
100

Physician interpretation of variants of uncertain significance.
Sarah K Macklin, Jessica L Jackson, Paldeep S Atwal, Stephanie L Hines. Fam Cancer 2019
25
100

Patients' Medical and Psychosocial Experiences After Detection of a CDH1 Variant With Multigene Panel Testing.
Jada G Hamilton, Jessica M Long, Amanda C Brandt, Jamie Brower, Heather Symecko, Erin E Salo-Mullen, Stephanie N Christian, Tricia Harstad, Fergus J Couch, Judy E Garber,[...]. JCO Precis Oncol 2019
10
100

Adverse events in cancer genetic testing: medical, ethical, legal, and financial implications.
Karina L Brierley, Erica Blouch, Whitney Cogswell, Jeanne P Homer, Debbie Pencarinha, Christine L Stanislaw, Ellen T Matloff. Cancer J 2012
66
100

Contralateral prophylactic mastectomy in breast cancer patients who test negative for BRCA mutations.
Marissa Howard-McNatt, Rebecca W Schroll, Gail J Hurt, Edward A Levine. Am J Surg 2011
17
100

Multi-gene panel testing for hereditary cancer susceptibility in a rural Familial Cancer Program.
David J Hermel, Wendy C McKinnon, Marie E Wood, Marc S Greenblatt. Fam Cancer 2017
11
100

The counsellees' view of an unclassified variant in BRCA1/2: recall, interpretation, and impact on life.
Joël Vos, Wilma Otten, Christi van Asperen, Anna Jansen, Fred Menko, Aad Tibben. Psychooncology 2008
80
100

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. Ann Intern Med 2009
100


Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients.
Heidi S Lumish, Hallie Steinfeld, Carrie Koval, Donna Russo, Elana Levinson, Julia Wynn, James Duong, Wendy K Chung. J Genet Couns 2017
61
100

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
824
100

Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer.
Allison W Kurian, Yun Li, Ann S Hamilton, Kevin C Ward, Sarah T Hawley, Monica Morrow, M Chandler McLeod, Reshma Jagsi, Steven J Katz. J Clin Oncol 2017
129
100

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
Douglas K Owens, Karina W Davidson, Alex H Krist, Michael J Barry, Michael Cabana, Aaron B Caughey, Chyke A Doubeni, John W Epling, Martha Kubik, C Seth Landefeld,[...]. JAMA 2019
107
100

Prospective Study of Surgical Decision-making Processes for Contralateral Prophylactic Mastectomy in Women With Breast Cancer.
Patricia A Parker, Susan K Peterson, Isabelle Bedrosian, Melissa A Crosby, Yu Shen, Dalliah M Black, Gildy Babiera, Henry M Kuerer, Jun Ying, Wenli Dong,[...]. Ann Surg 2016
50
100

Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer Risk.
Gregory E Idos, Allison W Kurian, Charité Ricker, Duveen Sturgeon, Julie O Culver, Kerry E Kingham, Rachel Koff, Nicolette M Chun, Courtney Rowe-Teeter, Alexandra P Lebensohn,[...]. JCO Precis Oncol 2019
2
100

Risk management decisions in women with BRCA1 and BRCA2 mutations.
Rosemary Morgan, Audrey Brown, Kelly Jo Hamman, Jone Sampson, Arpana Naik, Kristen Massimino. Am J Surg 2018
3
100

The influence of BRCA variants of unknown significance on cancer risk management decision-making.
Jing Yi Chern, Sarah S Lee, Melissa K Frey, Jessica Lee, Stephanie V Blank. J Gynecol Oncol 2019
6
100

Contralateral Risk-Reducing Mastectomy in Breast Cancer Patients Who Undergo Multigene Panel Testing.
Brittany L Murphy, Min Yi, Banu K Arun, Angelica M Gutierrez Barrera, Isabelle Bedrosian. Ann Surg Oncol 2020
4
100

Impact of Multigene Panel Testing on Surgical Decision Making in Breast Cancer Patients.
Holly J Pederson, Dharmesh Gopalakrishnan, Ryan Noss, Courtney Yanda, Charis Eng, Stephen R Grobmyer. J Am Coll Surg 2018
13
100

The impact of communicating uncertain test results in cancer genetic counseling: A systematic mixed studies review.
Niki M Medendorp, Pomme E A van Maarschalkerweerd, Laxsini Murugesu, Joost G Daams, Ellen M A Smets, Marij A Hillen. Patient Educ Couns 2020
5
100

Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer.
Nisreen Elsayegh, Rachel D Webster, Angelica M Gutierrez Barrera, Heather Lin, Henry M Kuerer, Jennifer K Litton, Isabelle Bedrosian, Banu K Arun. Cancer Med 2018
10
100

Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award.
Mary-Claire King, Ephrat Levy-Lahad, Amnon Lahad. JAMA 2014
172
100

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
783
100

Adverse events in cancer genetic testing: the third case series.
Danielle C Bonadies, Karina L Brierley, Rachel E Barnett, Melanie D Baxter, Talia Donenberg, Whitney L Ducaine, Michelle E Ernst, Jeanne Homer, Megan Judkins, Niki M Lovick,[...]. Cancer J 2014
26
100


Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress.
J O Culver, C D Brinkerhoff, J Clague, K Yang, K E Singh, S R Sand, J N Weitzel. Clin Genet 2013
57
100

Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
Stephanie M Wong, Rachel A Freedman, Yasuaki Sagara, Fatih Aydogan, William T Barry, Mehra Golshan. Ann Surg 2017
159
100

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
100


Clinical Decision-Making in Patients with Variant of Uncertain Significance in BRCA1 or BRCA2 Genes.
Jessemae L Welsh, Tanya L Hoskin, Courtney N Day, Abigail S Thomas, Jodie A Cogswell, Fergus J Couch, Judy C Boughey. Ann Surg Oncol 2017
34
100

Impact of an embedded genetic counselor on breast cancer treatment.
Holly J Pederson, Najaah Hussain, Ryan Noss, Courtney Yanda, Colin O'Rourke, Charis Eng, Stephen R Grobmyer. Breast Cancer Res Treat 2018
16
100

Rayyan-a web and mobile app for systematic reviews.
Mourad Ouzzani, Hossam Hammady, Zbys Fedorowicz, Ahmed Elmagarmid. Syst Rev 2016
100

Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review.
Kandice K Ludwig, Joan Neuner, Annabelle Butler, Jennifer L Geurts, Amanda L Kong. Am J Surg 2016
77
100

Variants of unknown significance in BRCA testing: impact on risk perception, worry, prevention and counseling.
S Richter, I Haroun, T C Graham, A Eisen, A Kiss, E Warner. Ann Oncol 2013
60
100

Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.
Allison W Kurian, Kevin C Ward, Ann S Hamilton, Dennis M Deapen, Paul Abrahamse, Irina Bondarenko, Yun Li, Sarah T Hawley, Monica Morrow, Reshma Jagsi,[...]. JAMA Oncol 2018
67
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.